| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44ae178fe5ea1fd193b8e5e1baf1ab3b |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 |
| filingDate |
2020-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f76d77d7d0c579040eb19a35782ecefb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3124582213bb40cfa83426b59807e3d |
| publicationDate |
2020-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2020100021-A4 |
| titleOfInvention |
Hydrogel, pharmaceutical composition comprising same, and application thereof |
| abstract |
Abstract The present invention provides a temperature-sensitive hydrogel for treating concurrent damage of diabetes, which includes KGF-2, FGF-21, poloxamer 407, sodium heparin, glycerin and water. The hydrogel is particularly suitable for use in the early stages of the treatment of the injury. In addition, the present invention also provides an auxiliary material composition and the like for preparing the hydrogel. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114617839-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114617839-A |
| priorityDate |
2018-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |